Astodrimer sodium antiviral nasal spray for reducing respiratory infections is safe and well tolerated in a randomized controlled trial

por Castellarnau, Alex, Heery, Graham P., Seta, Aynaz, Luscombe, Carolyn A., Kinghorn, George R., Button, Peter, McCloud, Philip, Paull, Jeremy R. A.
Publicado 2022

A phase 2, double-blind, multicenter, randomized, placebo-controlled, dose‑ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis

por Waldbaum, Arthur S., Schwebke, Jane R., Paull, Jeremy R. A., Price, Clare F., Edmondson, Stephanie R., Castellarnau, Alex, McCloud, Philip, Kinghorn, George R.
Publicado 2020

A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis

por Schwebke, Jane R., Carter, Belvia A., Waldbaum, Arthur S., Agnew, Kathy J., Paull, Jeremy R.A., Price, Clare F., Castellarnau, Alex, McCloud, Philip, Kinghorn, George R.
Publicado 2021

Cost-Effectiveness of Early Treatment with First-Line NNRTI-Based HAART Regimens in the UK, 1996-2006

por Beck, Eduard J., Mandalia, Sundhiya, Lo, Gary, Sharott, Peter, Youle, Mike, Anderson, Jane, Baily, Guy, Brettle, Ray, Fisher, Martin, Gompels, Mark, Kinghorn, George, Johnson, Margaret, McCarron, Brendan, Pozniak, Anton, Tang, Alan, Walsh, John, White, David, Williams, Ian, Gazzard, Brian
Publicado 2011

Rising Population Cost for Treating People Living with HIV in the UK, 1997-2013

por Mandalia, Sundhiya, Mandalia, Roshni, Lo, Gary, Chadborn, Tim, Sharott, Peter, Youle, Mike, Anderson, Jane, Baily, Guy, Brettle, Ray, Fisher, Martin, Gompels, Mark, Kinghorn, George, Johnson, Margaret, McCarron, Brendan, Pozniak, Anton, Tang, Alan, Walsh, John, White, David, Williams, Ian, Gazzard, Brian, Beck, Eduard J.
Publicado 2010